[RDHL] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
13-Nov-2017
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 32.87%
YoY- -24.72%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 21,461 1,590 1,359 2,001 100 0 1 426.36%
PBT -24,331 -11,691 -7,684 -10,413 -8,349 -6,560 -5,328 28.77%
Tax -378 212 -364 -787 1,013 -80 0 -
NP -24,331 -11,691 -7,684 -10,413 -8,349 -6,560 -5,328 28.77%
Tax Rate - - - - - - - -
Total Cost 45,792 13,281 9,043 12,414 8,449 6,560 5,329 43.07%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -113.37 -735.28 -565.42 -520.39 -8,349.00 0.00 -532,800.00 -75.53%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -25.69 -13.89 -11.68 -20.70 -24.00 -21.04 -24.25 0.96%
EPS Diluted -25.69 -13.89 -11.68 -20.00 -24.00 -20.64 -24.25 0.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.